5//SEC Filing
AQUINOX PHARMACEUTICALS, INC 5
Accession 0001209191-15-010932
$NGNECIK 0001404644operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:30 PM ET
Size
4.8 KB
Accession
0001209191-15-010932
Insider Transaction Report
Form 5
SHREWSBURY STEPHEN B
CMO; Senior VP Clinical Dev.
Transactions
- Purchase
Common Stock
2014-09-02$8.22/sh+400$3,288→ 400 total
Documents
Issuer
AQUINOX PHARMACEUTICALS, INC
CIK 0001404644
Entity typeoperating
Related Parties
1- filerCIK 0001404644
Filing Metadata
- Form type
- 5
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:30 PM ET
- Size
- 4.8 KB